R. Carrillo et al. / Tetrahedron 61 (2005) 8177–8191
8187
1.77–1.88 (m, 2H), 1.93–2.04 (m, 2H) 2.20–2.27 (m, 2H),
3.50 (ddd, JZ2.2, 11.6, 11.6 Hz, 2H), 3.90–4.07 (m, 4H),
4.34 (s, 2H), 6.17 (d, JZ9.6 Hz, 2H), 6.87 (dd, JZ5.9,
9.6 Hz, 2H); 13C NMR (CDCl3) d 19.9 (t), 27.2 (t), 66.6 (d),
67.4 (t), 73.1 (d), 124.6 (d), 141.7 (d), 163.9 (s); IR (film)
(cmK1) 2930, 1715, 1252, 1090; MS (FAB) m/z (relative
intensity) 155 (MCH)C(100), 154 (M)C(23), 95 (24), 69
(52), 54 (56).
stirred for 3–4 h. Then, the mixture was diluted with Et2O
and washed with a saturated aqueous solution of NaHCO3.
The aqueous layer was extracted with Et2O and the
combined organic layers were dried (MgSO4), filtered and
concentrated. Silica gel column chromatography of the
residue gave benzyl ester 28 (200 mg, 96% yield) as an oil:
1
[a]2D5K7.4 (c 1.1, CHCl3); H NMR (CDCl3) d 1.36–1.39
(m, 2H), 1.70–2.00 (m, 6H), 2.44 (dd, JZ5.0, 15.9 Hz, 1H),
2.52–2.71 (m, 3H), 3.47 (dd, JZ2.0, 11.6, 11.6, 11.6,
11.6 Hz, 2H), 3.62 (s, 1H), 3.80–3.83 (m, 1H), 3.91–3.99
(m, 3H), 4.90 (s, 1H), 5.07 (d, JZ12.4 Hz, 1H), 5.12 (d, JZ
12.4 Hz, 2H), 7.27–7.34 (m, 5H); 13C NMR (CDCl3) d 19.7
(t), 20.3 (t), 27.7 (t), 30.3 (t), 37.1 (t), 37.5 (t), 66.2 (d), 66.3
(t), 68.0 (t), 68.2 (t), 68.6 (d), 74.6 (d), 76.4 (d), 128.0 (d),
128.1 (d), 128.4 (d), 137.7 (s), 170.7 (s), 170.8 (s); IR (film)
(cmK1) 3452, 2950, 2855, 1734; MS (FAB) m/z (relative
intensity) 393 (MCH)C (8), 307 (7), 154 (47), 136 (37), 91
(100). HRMS (FAB) calcd for C21H29O7 (MCH)C:
393.1913, found: 393.1891.
4.1.10. Preparation of benzyl (2E)-3-[(2R,3R)-tetra-
hydro-3-hydroxy-2H-pyran-2-yl]-2-propenoate (26).
The same procedure used above to obtain compound 22
was applied to 14 on a 600 mg (2.4 mmol) scale, using in the
Wittig–Horner step the sodium salt of benzyl dimethyl-
phosphonoacetate in dry benzene and followed by deprotec-
tion of the silyl ether with HF in CH3CN, yielding 26
(525 mg, 82% yield) as a white solid: mp 114–117 8C:
[a]2D5K19.6 (c 0.75, CHCl3); H NMR (CDCl3) d 1.42 (m,
1
1H), 1.73 (m, 1H), 1.89–2.04 (m, 2H), 3.52 (ddd, JZ2.3,
11.9, 11.9 Hz, 1H), 3.83 (s, 1H), 4.02–4.08 (m, 2H), 5.18 (s,
2H), 6.17 (dd, JZ2.0, 15.7 Hz, 1H), 6.92 (dd, JZ2.0,
15.7 Hz, 1H), 7.35 (m, 5H); 13C NMR (CDCl3) d 19.8 (t),
30.2 (t), 66.3 (t), 66.5 (d), 68.3 (t), 78.6 (d), 122.0 (d), 128.1
(d), 128.2 (d), 128.5 (d), 136.0 (q), 145.7 (d), 166.0 (s);
MS m/z (relative intensity) 171 (MKBn)C (6), 146 (18),
88 (39), 71 (54), 57 (100). HRMS calcd for C8H11O4
(MKBn)C: 171.0657, found: 171.0658.
4.1.13. Preparation of macrolide 1. A mixture of the
benzyl ester 28 (200 mg, 0.5 mmol) and Pd(OH)2 (10 mg) in
EtOAc (5.1 mL) was placed under H2 atmosphere. The
reaction mixture was vigorously stirred until TLC showed
complete conversion to the hydroxyl acid. The mixture was
filtered through a pad of Celite. The solvent was removed
under reduced pressure and the residue was used without
further purification.
4.1.11. Preparation of (2R,3R)-2-[2-(benzyloxy)-2-
oxoethyl]tetrahydro-2H-pyran-3-yl ((2R,3R)-3-{[tert-
butyl(dimethyl)silyl]oxy}tetrahydro-2H-pyran-2-yl)
acetate (27). To a stirred solution of the acid 16 (150 mg,
0.6 mmol) in dry CH2Cl2 (3 mL) under argon were added
sequentially with stirring DMAP (87 mg, 0.7 mmol),
alcohol 17 (137 mg, 0.6 mmol) and camphorsulfonic acid
(38 mg, 0.2 mmol) at rt. The mixture was stirred for 15 min,
and DCC (147 mg, 0.7 mmol) was slowly added. The
reaction mixture was additionally stirred for 5 h and diluted
in CH2Cl2, filtered through a pad of Celite and washed with
a 5% (w/v) HC1 aqueous solution, a saturated aqueous
solution of NaHCO3 and saturated brine. The organic phase
was dried over MgSO4, concentrated, and purified by
chromatography on silica gel, to afford the benzyl ester 27
To a mixture of hydroxyl acid and 2,20-dipyridyl disulfide
(145 mg, 0.7 mmol) in dry toluene (1.8 mL) at rt was added
triphenylphosphine (175 mg, 0.7 mmol) in one portion. The
reaction mixture was stirred for 6 h prior to diluting with dry
toluene (55 mL, 0.01 M) and then the mixture was refluxed
overnight. The solvent was removed under vacuum and the
residue was purified by chromatography on silica gel, to
yield macrodiolide 1 (36 mg, 25% yield) and g-lactone 20
(36 mg, 50% yield). Macrodiolide 1: white solid: mp 130–
1
133 8C: [a]2D5C9.2 (c 1.4, CHCl3); H NMR (CDCl3) d
1.51–1.53 (m, 2H), 1.82–1.96 (m, 6H), 2.66 (dd, JZ5.3,
13.3 Hz, 2H), 2.82 (dd, JZ8.2, 13.3 Hz, 2H), 3.50–3.55 (m,
2H), 3.79–3.84 (m, 2H), 4.05–4.09 (m, 2H), 4.86–4.89 (m,
2H); 13C NMR (CDCl3) d 21.7 (t), 26.6 (t), 37.7 (t), 65.9 (t),
69.5 (d), 73.8 (d), 171.1 (s); IR (film) (cmK1) 2952, 2856,
1735; MS (FAB) m/z (relative intensity) 285 (MCH) (100),
225 (12), 220 (10). HRMS (FAB) calcd for C14H21O6 (MC
H): 285.1338, found: 285.1332.
(266 mg, 96% yield): [a]2D5K1.4 (c 1.4, CHCl3); H NMR
1
(CDCl3) d 0.03 (s, 3H), 0.05 (s, 3H), 0.90 (s, 9H), 1.28–1.42
(m, 2H), 1.65–1.98 (m, 6H), 2.44 (dd, JZ4.5, 15.9 Hz, 2H),
2.59–2.71 (m, 2H), 3.48 (ddddd, JZ2.0, 11.6, 11.6, 11.6,
11.6 Hz, 2H), 3.70 (s, 1H), 3.83–3.94 (m, 2H), 3.94–3.98
(m, 2H), 4.93 (s, 1H), 5.10 (d, JZ12.4 Hz, 1H), 5.12 (d, JZ
12.4 Hz, 2H), 7.28–7.36 (m, 5H); 13C NMR (CDCl3) dK4.8
(q), K4.5 (q), 18.1 (s), 20.4 (t), 25.9 (q), 27.8 (t), 30.9 (t),
37.3 (t), 66.4 (t), 67.2 (d), 67.4 (t), 68.1 (t), 68.6 (d), 74.7 (d),
76.3 (d), 128.1 (d), 128.5 (d), 135.8 (s), 170.8 (s), 171.2 (s);
IR (film) (cmK1) 2952, 2930, 2856, 1737; MS m/z (relative
intensity) 449 (MKBu-t)C (0.89), 307 (7), 233 (26), 187
(14), 91 (100). HRMS calcd for C23H33O7Si (MKBu-t)C:
449.1996, found: 449.1979.
4.1.14. Preparation of (2R,3R)-2-{(1E)-2-[benzyloxy-
carbonyl]vinyl}-tetrahydro-2H-pyran-3-yl 3-[(3S,2R)-3-
(tert-butyldimethylsilyloxy)-(tetrahydro-2H-pyran-2-
yl)]prop-2-(2E)-enoate (29). The same procedure used
above to obtain compound 27 was applied to the acid 23 on
a 350 mg (1.2 mmol) scale and alcohol 26 (320 mg,
1.2 mmol), yielding 29 (532 mg, 82% yield) as a colourless
oil: [a]2D5K9.8 (c 1.25, CHCl3); 1H NMR (CDCl3) d 0.03 (s,
3H), 0.01 (s, 3H), 0.84 (s, 9H), 1.30–1.44 (m, 2H), 1.65–
2.04 (m, 6H), 3.50 (m, 2H), 3.79 (s, 1H), 3.97–4.13 (m, 3H),
4.16 (s, 1H), 5.05 (s, 1H), 5.14 (s, 2H), 6.05 (d, JZ17.6 Hz,
1H), 6.11 (d, JZ17.6 Hz, 1H), 6.85 (m, 2H), 7.26–7.32 (m,
5H); 13C NMR (CDCl3) d 4.8 (q), 18.1 (s), 20.5 (t), 25.7 (q),
27.8 (t), 31.2 (t), 37.3 (t), 66.0 (t), 67.2 (t), 67.6 (d), 67.7 (t),
68.2 (d), 77.0 (d), 78.8 (d), 121.6 (d), 121.9 (d), 128.0 (d),
4.1.12. Preparation of (2R,3R)-2-[2-(benzyloxy)-2-
oxoethyl]tetrahydro-2H-pyran-3-yl [(2R,3R)-3-hydroxy-
tetrahydro-2H-pyran-2-yl]acetate (28). To a solution of
the benzyl ester 27 (266 mg, 0.5 mmol) in CH3CN (5.3 mL)
at 0 8C, was added HF (48%, 0.6 mL) and the reaction was